Sci Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CG Oncology Reports Bladder Cancer Treatment - Orange County Business Journal

CG Oncology Reports Bladder Cancer Treatment - Orange County Business Journal
ocbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ocbj.com Daily Mail and Mail on Sunday newspapers.

United statesSan antonioMerck keytrudaSam slutskyArthur kuanAmerican urological association annual meetingDrug administrationAmerican cancer societyAmerican society of clinical oncologyShiong immunitybio incCg oncology incFerring pharmaceuticalsAmerican urological associationAnnual meetingSci capitalFast track designation

TScan Therapeutics Announces Exercise of Underwriters Option to Purchase Additional Shares

TScan Therapeutics Announces Exercise of Underwriters Option to Purchase Additional Shares
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkMaghan meyersHeather savelleHc wainwright coGlobe newswire tscan therapeutics incMorgan stanley coTd securities united statesNeedham companyProspectus departmentExchange commissionTscan therapeutics incMorgan stanleyTherapeutics announces exerciseUnderwriter optionPurchase additional

TScan Therapeutics Announces Exercise of Underwriters

WALTHAM, Mass., April 24, 2024 (GLOBE NEWSWIRE) TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the.

United statesNew yorkHeather savelleMaghan meyersHc wainwright coMorgan stanleyTscan therapeutics incExchange commissionProspectus departmentTd securities united statesNeedham companyMorgan stanley coGlobe newswire tscan therapeutics incSci capitalNasdaq tcrxTscan therapeutics

INmune Bio Inc Raises Approximately $4 8 Million in Gross Proceeds through Registered Direct Offering with Officers, Employees and Directors Purchasing Approximately 20% of the Offering

Boca Raton, Florida - INmune Bio, Inc. , a clinical-stage immunology company focused on developing treatments that harness the patient s innate immune system to fight disease, today announced today.

New yorkUnited statesBoca ratonJason nelsonDavid mossInmune bioCompany quarterly reports on formLifesci capitalCompany annual report on formDrug administrationCompany phaseCompany current reports on formInmune bio incExchange commissionTermination dateEarly alzheimer

INmune Bio (INMB) Prices 572K Share Offering at $8 32/sh

INmune Bio (INMB) Prices 572K Share Offering at $8 32/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesExchange commissionCompany phaseInmune bio incLifesci capitalEarly alzheimerSci capital